Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tracks Real-World use of eczema drug abrocitinib

NCT ID NCT06353087

Ongoing Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study follows 200 people aged 12 and older with moderate-to-severe eczema who are starting a new prescription of abrocitinib. Researchers will track how much their skin improves over 12 months using standard eczema severity scores. The goal is to see how well the drug works in real-world settings, outside of controlled clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
abrocitinib
What this could lead to
If successful, this study could confirm that abrocitinib works well in real-world settings for people with moderate-to-severe eczema, helping doctors make better treatment decisions.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It only follows people for 12 months, and long-term effects or rare side effects may not be captured.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema dermatitis Eczema immune system disorder skin disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DERMATITIS DERMATITIS ATOPIC ECZEMA IMMUNE SYSTEM DISEASES JANUS KINASE INHIBITORS SKIN DISEASES

Contacts and locations

Locations

  • Chang Gung Hospital Linkou

    Taoyuan, 333, Taiwan

  • Chang Gung Memorial Hospital at Kaohsiung

    Kaohsiung City, 83301, Taiwan

  • Kaohsiung Medical University Hospital

    Kaohsiung City, 807377, Taiwan

  • MacKay Memorial Hospital

    Taipei, 10449, Taiwan

  • NTUH

    Taipei, 100, Taiwan

  • Taipei Medical University - Shuang Ho Hospital

    New Taipei City, 23561, Taiwan

  • Taipei Veterans General Hospital

    Taipei, 11217, Taiwan

  • Tri-Service General Hospital

    Taipei, 11490, R.O.C., Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.